Saturday, December 13, 2025 | 12:04 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Kopran hits 52-week high after Crisil upgrades rating outlook to 'Positive'

The rating agency reaffirmed its 'CRISIL BBB' rating on long term bank facilities, while short term ratings has been reaffirmed at 'CRISIL A3+'

The government is now trying to understand how long it will take before the drug’s production can start in India
premium

Trading volumes on the counter more-than-doubled with a combined 1.06 million equity shares changing hands on the NSE and BSE till the time of writing of this report

SI Reporter Mumbai
Shares of Kopran were locked in the 5 per cent upper circuit band at Rs 97.35 on the BSE on Tuesday, gaining 10 per cent in the past four trading days, after rating agency Crisil revised its outlook on the long term bank facilities of the company to 'Positive' from 'Stable'. The rating agency reaffirmed its 'CRISIL BBB' rating on long term bank facilities, while short term ratings has been reaffirmed at 'CRISIL A3+'.

The stock of the pharmaceutical company was trading at its 52-week high level. In the past one month, it has rallied 39 per cent as compared to